Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Phillip J. DiSaia Bradley J. Monk |
| Publication date | July 27, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |